Literature DB >> 11891045

Genomic organization and differential expression of Kalirin isoforms.

Clifton E McPherson1, Betty A Eipper, Richard E Mains.   

Abstract

Multidomain guanine nucleotide (GDP/GTP) exchange factor (GEF) proteins coordinate diverse inputs that signal the actin cytoskeleton. Mammals have two such proteins (Kalirin, Trio), while Drosophila has one, which plays essential roles within and outside the nervous system. For Kalirin, numerous isoforms containing different combinations of functional domains are generated through alternative splicing and use of alternative transcriptional start sites. These different isoforms potentially allow a wide variety of proteins to interact with Kalirin, thereby affecting the activity of the functional domains. Humans, like rats, express a large set of Kalirin isoform mRNAs, and we identified a novel Kalirin isoform, containing only the second GEF domain. Kalirin isoforms are predominantly expressed in the brain, while Trio is expressed in a wider variety of tissues. Alternative splicing and transcription of Kalirin are differentially regulated during development in rats and humans, resulting in expression of isoforms of Kalirin containing different functional domains at different times and locations. The prevalence of Kalirin in the cortex throughout life suggests roles in axonal development and the mature brain.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11891045     DOI: 10.1016/s0378-1119(02)00386-4

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  38 in total

1.  Kalirin Dbl-homology guanine nucleotide exchange factor 1 domain initiates new axon outgrowths via RhoG-mediated mechanisms.

Authors:  Victor May; Martin R Schiller; Betty A Eipper; Richard E Mains
Journal:  J Neurosci       Date:  2002-08-15       Impact factor: 6.167

2.  Kalirin-7, an important component of excitatory synapses, is regulated by estradiol in hippocampal neurons.

Authors:  Xin-Ming Ma; Jian-Ping Huang; Eun-Ji Kim; Qing Zhu; George A Kuchel; Richard E Mains; Betty A Eipper
Journal:  Hippocampus       Date:  2010-03-23       Impact factor: 3.899

3.  Kalirin/Trio Rho guanine nucleotide exchange factors regulate a novel step in secretory granule maturation.

Authors:  Francesco Ferraro; Xin-Ming Ma; Jacqueline A Sobota; Betty A Eipper; Richard E Mains
Journal:  Mol Biol Cell       Date:  2007-09-19       Impact factor: 4.138

4.  Kalirin/Trio Rho GDP/GTP exchange factors regulate proinsulin and insulin secretion.

Authors:  Quinn Dufurrena; Nils Bäck; Richard E Mains; Louis Hodgson; Herbert Tanowitz; Prashant Mandela; Elizabeth Eipper; Regina Kuliawat
Journal:  J Mol Endocrinol       Date:  2018-11-01       Impact factor: 5.098

5.  Rho-guanine nucleotide exchange factors during development: Force is nothing without control.

Authors:  Shai Mulinari; Udo Häcker
Journal:  Small GTPases       Date:  2010-07

6.  Kalirin-9 and Kalirin-12 Play Essential Roles in Dendritic Outgrowth and Branching.

Authors:  Yan Yan; Betty A Eipper; Richard E Mains
Journal:  Cereb Cortex       Date:  2014-08-21       Impact factor: 5.357

Review 7.  Reversing synapse loss in Alzheimer's disease: Rho-guanosine triphosphatases and insights from other brain disorders.

Authors:  Roger Lefort
Journal:  Neurotherapeutics       Date:  2015-01       Impact factor: 7.620

Review 8.  KALRN: A central regulator of synaptic function and synaptopathies.

Authors:  Euan Parnell; Lauren P Shapiro; Roos A Voorn; Marc P Forrest; Hiba A Jalloul; Daniel D Loizzo; Peter Penzes
Journal:  Gene       Date:  2020-11-13       Impact factor: 3.688

9.  Autonomous functions for the Sec14p/spectrin-repeat region of Kalirin.

Authors:  Martin R Schiller; Francesco Ferraro; Yanping Wang; Xin-ming Ma; Clifton E McPherson; Jacqueline A Sobota; Noraisha I Schiller; Richard E Mains; Betty A Eipper
Journal:  Exp Cell Res       Date:  2008-05-29       Impact factor: 3.905

10.  Kalirin12 interacts with dynamin.

Authors:  Xiaonan Xin; Chana A Rabiner; Richard E Mains; Betty A Eipper
Journal:  BMC Neurosci       Date:  2009-06-17       Impact factor: 3.288

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.